CFTR and lung disorder: Among these models, the CFTRG551D/G551D ferret was the first to evaluate CFTR modulator therapy in utero and postnatally, demonstrating the safety and efficacy of IVA therapy to protect from MI, pancreatitis, and lung disease (21).